Entactbio Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 23

Employees

  • Latest Deal Type
  • Series A2

  • Latest Deal Amount
  • $10M

  • Investors
  • 14

Entactbio General Information

Description

Developer of a biotechnology research company designed to enhance the function of beneficial proteins. The company engages in natural cellular mechanisms by offering small-molecule drugs to create enhancement-targeting chimeric medicines, enabling patients to harness the ability of enzymes to regulate proteins.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 65 Grove Street
  • Suite 303
  • Watertown, MA 02472
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 65 Grove Street
  • Suite 303
  • Watertown, MA 02472
  • United States
+1 (617)

Entactbio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Entactbio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A2) 03-Jun-2026 $10M Completed Generating Revenue
3. Later Stage VC (Series A2) 15-May-2024 Completed Generating Revenue
2. Early Stage VC (Series A) 06-Dec-2022 $81M $86.4M Completed Generating Revenue
1. Seed Round 25-Oct-2019 $5.4M $5.4M Completed Startup
To view Entactbio’s complete valuation and funding history, request access »

Entactbio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2
Series A1
Series A 10,664,312 $0.000010 8% $2.49 $2.49 1x $2.49 13.28%
Seed 4,000,000 $0.000010 8% $1.35 $1.35 1x $1.35 4.98%
To view Entactbio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Entactbio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biotechnology research company designed to enhance the function of beneficial proteins. The company engag
Drug Discovery
Watertown, MA
23 As of 2026

Seattle, WA
 

Philadelphia, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Entactbio Competitors (3)

One of Entactbio’s 3 competitors is Arzeda, a Venture Capital-Backed company based in Seattle, WA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arzeda Venture Capital-Backed Seattle, WA
Spark Therapeutics Formerly VC-backed Philadelphia, PA
Codexis Formerly VC-backed Redwood City, CA
You’re viewing 3 of 3 competitors. Get the full list »

Entactbio Patents

Entactbio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022148822-A1 Usp5 binding survival-targeting chimeric (surtac) molecules & uses thereof Inactive 07-Jan-2021
WO-2022148821-A1 Usp7 binding survival-targeting chimeric (surtac) molecules & uses thereof Inactive 07-Jan-2021
WO-2020169650-A1 Survival-targeting chimeric (surtac) molecules Inactive 21-Feb-2019 A61K47/6811

Entactbio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Entactbio Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
WEHI Ventures Corporate Venture Capital Minority
Revelation Partners Venture Capital Minority
Abingworth Venture Capital Minority
Brandon Biocatalyst Venture Capital Minority
Brandon Capital Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Entactbio FAQs

  • When was Entactbio founded?

    Entactbio was founded in 2019.

  • Where is Entactbio headquartered?

    Entactbio is headquartered in Watertown, MA.

  • What is the size of Entactbio?

    Entactbio has 23 total employees.

  • What industry is Entactbio in?

    Entactbio’s primary industry is Drug Discovery.

  • Is Entactbio a private or public company?

    Entactbio is a Private company.

  • What is the current valuation of Entactbio?

    The current valuation of Entactbio is .

  • What is Entactbio’s current revenue?

    The current revenue for Entactbio is .

  • How much funding has Entactbio raised over time?

    Entactbio has raised $137M.

  • Who are Entactbio’s investors?

    WEHI Ventures, Revelation Partners, Abingworth, Brandon Biocatalyst, and Brandon Capital are 5 of 14 investors who have invested in Entactbio.

  • Who are Entactbio’s competitors?

    Arzeda, Spark Therapeutics, and Codexis are competitors of Entactbio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process